Arrivent Biopharma (AVBP)'s 30-day implied volatility (IV30) was 84.8% at the close on October 20, 2026, up from 80.7% the day before, against a 52-week range of 33.7% to 256.6%. Its 20-day historical volatility was 72.6%.
Data as of October 20, 2026.